NeoGenisis Drug Discovery Incorporated Company Profile

16:35 EDT 17th March 2018 | BioPortfolio

We are focused on the discovery of small molecule drugs on a proteome and genome-wide scale. We believe that we are the only company currently capable of delivering small molecule drug candidates for virtually every medically important protein encoded by the human genome and that the rate at which we are forming discovery alliances validates the vast opportunity presented by the convergence of our technologies with genomics and proteomics. We are leveraging our chemical genomics strategy through collaborations with biotechnology and pharmaceutical companies as well as our internal discovery efforts.


840 Memorial Drive, 5th Florr
United States of America


Phone: 617 868 1500

News Articles [1862 Associated News Articles listed on BioPortfolio]

How Robot Math and Smartphones Led Researchers to a Drug Discovery Breakthrough

NewsResearchers have figured out how to apply an algorithm originally designed to help robots move to an entirely different problem: drug discovery.

The Current issue of “The view from here” is concerned with nanoscience in drug discovery.

The topic of this month’s newsletter from Drug Discovery Today is “nanoscience in drug discovery”

Blue Oak and PsychoGenics partner on drug discovery

Blue Oak Pharmaceuticals and PGI Drug Discovery have entered into a partnership to discover and optimize novel treatments for brain disorders and psychiatric conditions. Under the terms of the agreeme...

The Current issue of “The view from here” is concerned with Regulatory aspects of Drug Discovery.

The topic of this month’s newsletter from Drug Discovery Today is “Regulatory aspects of Drug Discovery”.

A Popular Tool for Drug Discovery Just Got 10 Times Faster

NewsResearchers at Purdue University just made high throughput screening, a process often used in drug discovery, 10 times faster than previous methods.

Beacon enters drug discovery collaboration with Janssen

US-based drug discovery firm Beacon Discovery has entered a multi-year collaboration agreement with Janssen Pharmaceuticals for small molecule compounds to...Read More... The post Beacon enters drug d...

X-Chem, AstraZeneca expand drug discovery partnership

X-Chem, a small molecule discovery specialist, has expanded its existing global drug discovery and technology transfer collaboration with AstraZeneca.

AHA, LLNL announce partnership to speed up drug discovery

The American Heart Association (AHA) and Lawrence Livermore National Laboratory (LLNL) are joining forces to reduce the cost of drug discovery and the time it takes a new drug to enter the marketplac...

PubMed Articles [2992 Associated PubMed Articles listed on BioPortfolio]

Protac-induced Protein Degradation in Drug Discovery: Breaking the Rules - or Just Making New Ones?

Targeted protein degradation, using bifunctional small molecules (Protacs) to remove specific proteins from within cells, has emerged as a novel drug discovery strategy with the potential to offer the...

From machine learning to deep learning: progress in machine intelligence for rational drug discovery.

Machine intelligence, which is normally presented as artificial intelligence, refers to the intelligence exhibited by computers. In the history of rational drug discovery, various machine intelligence...

Fragment-Based Drug Discovery of Phosphodiesterase Inhibitors.

Phosphodiesterases are proving to be fruitful targets for drug discovery. At the same time fragment-based drug discovery has matured into a powerful and widely applied technique. In this communication...

Allosteric Tuning of Caspase-7: a Fragment-Based Drug Discovery Approach.

The caspase family of cysteine proteases are highly sought after drug targets due to their essential roles in apoptosis, proliferation and inflammation pathways. High throughput screening efforts to d...

Pathway-based technologies for early drug discovery.

Although the traditional drug discovery approach has led to the development of many successful drugs, the attrition rates remain high. Recent advances in systems-oriented approaches (systems-biology a...

Clinical Trials [2175 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Biologic Basis of Liver Cancer From Chronic Hepatitis B

The focus of the study is to identify viral factors and host immune responses that differentiate HBV-related HCC patients from HBV patients who have not progressed to HCC. To that end, the...

Companies [2365 Associated Companies listed on BioPortfolio]

NeoGenisis Drug Discovery Incorporated

We are focused on the discovery of small molecule drugs on a proteome and genome-wide scale. We believe that we are the only company currently capable of delivering small molecule drug candidates for ...


PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Argenta Discovery Ltd.

Argenta Discovery is a privately held drug discovery company, applying its integrated medicinal chemistry, biology, ADMET and CADD expertise to drive drug discovery programmes. Argenta has a successfu...

Drug Discovery Industr

Welcome to Drug Discovery Online, the first Internet site devoted exclusively to drug discovery and early-stage drug development.Drug Discovery Online covers drug discovery like no other Internet site...


Beryllium is shaping the future of collaborative drug discovery. Our proven teams of drug discovery professionals are passionate about unlocking the therapeutic potential of both ...

More Information about "NeoGenisis Drug Discovery Incorporated" on BioPortfolio

We have published hundreds of NeoGenisis Drug Discovery Incorporated news stories on BioPortfolio along with dozens of NeoGenisis Drug Discovery Incorporated Clinical Trials and PubMed Articles about NeoGenisis Drug Discovery Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NeoGenisis Drug Discovery Incorporated Companies in our database. You can also find out about relevant NeoGenisis Drug Discovery Incorporated Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record